medivir.se Report : Visit Site

Technical data of the medivir.se

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host medivir.se. Currently, hosted in United States and its service provider is Corporation Service Company .

the related websites

bloomberg.com domainex.co.uk discuva.com xplico.com saundersboston.com cancertechnology.co.uk ukmi.nhs.uk aidsmap.com zoeharcombe.com brianmac.co.uk lifesciences.thomsonreuters.com doctor.net clomiphenecitrate50mgformen.com clomiphenecitrate50mgmen.com travelindependent.info 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

 om oss investerare nyheter & media english om oss medivir i korthet affärsmodell & strategi ledning ledningsgrupp styrelse investerare aktieinformation nyckeltal rapporter rapporter 2018 rapporter 2017 rapporter 2016 rapporter 2015 rapporter 2014 rapporter 2013 rapporter 2012 presentationer presentationer 2018 presentationer 2017 presentationer 2016 presentationer 2015 presentationer 2014 presentationer 2013 presentationer 2012 presentationer 2011 presentationer 2010 presentationer 2009 pressmeddelanden event bio europe delårsrapport januari - september 2018 bokslutskommuniké januari - december 2018 bolagsstyrning bolagsstämmor 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 nyheter & media pressmeddelanden mediabank blog målmedveten förändring av medivir framgångsrik utveckling i de kliniska projekten search medivir.se denna svenska version av medivir.com innehåller endast översättningar av utvalda delar av innehållet från engelska sidan. för fullständig information och tillgång till komplett innehåll hänvisar vi till medivir.com-sidan. engelska sidan - medivir.com from discovery to remedy medivir is a drug discovery and development company focusing on transformative cancer drugs. our research and development are based on our extensive expertise in protease inhibitor design and nucleoside/nucleotide science. our research > for those most in need medivir focuses on cancers of high unmet medical need to provide benefit to patients who so far have had few treatment options. our projects > partnering for breadth and depth thanks to our scientific knowledge, balanced project portfolio, collaborative culture and extensive industry experience we do this efficiently and with a high success rate. partnership > improving life for cancer patients through transformative drugs our current projects remetinostat topical hdac inhibitor more about remetinostat birinapant smac mimetic more about birinapant view all our current projects pressmeddelanden 2018-10-01 klinisk fas i/ii-studie av miv-818 påbörjad i patienter med levercancer läs mer 2018-09-10 medivir utser dr. linda basse till chief medical officer läs mer 2018-08-02 prövarinitierad klinisk fas ii-studie av remetinostat påbörjad i patienter med basalcellscancer läs mer läs nyheter & press releaser join our team 80 employees, 18 nationalities ongoing professional development healthy working environment. great science. meet our people partner with medivir partnering is an important element of our business strategy. together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale. read more kontakta medivir thank you for your message! we will get back to you shortly. have a nice day. välj ett ämne vad funderar du på? vad är ditt namn? företaget du arbetar på? vi behöver din e-postadress för att svara dig om du vill att vi hellre ringer dig, lämna ditt nummer skicka christine lind president and ceo +46 (0)8 407 46 41 [email protected] erik björk chief financial officer +46 (0)8 546 831 00 [email protected] posta medivir ab box 1086 se-141 22 huddinge besöksadress: lunastigen 7 telefon +46 (0)8 546 831 00 email [email protected]

URL analysis for medivir.se

http://www.medivir.se/investerare/bolagsstaemmor/2010
http://www.medivir.se/investerare/rapporter
http://www.medivir.se/investerare/presentationer
http://www.medivir.se/om-oss/ledning/styrelse
http://www.medivir.se/nyheter-media/blog/maalmedveten-foeraendring-av-medivir
http://www.medivir.se/nyheter-media/blog/framgaangsrik-utveckling-i-de-kliniska-projekten
http://www.medivir.se/investerare/event/bio-europe
http://www.medivir.se/investerare/pressmeddelanden/2018/medivir-utser-dr-linda-basse-till-chief-medical-officer
http://www.medivir.se/investerare/bolagsstaemmor/2014
http://www.medivir.se/investerare/aktieinformation
http://www.medivir.se/#play
http://www.medivir.se/investerare/bolagsstaemmor/2018
http://www.medivir.se/om-oss/affaersmodell-strategi
http://www.medivir.se/investerare/event/delaarsrapport-januari-september-2018
http://www.medivir.se/investerare/bolagsstaemmor/2013

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

# Copyright (c) 1997- IIS (The Internet Foundation In Sweden).
# All rights reserved.
# The information obtained through searches, or otherwise, is protected
# by the Swedish Copyright Act (1960:729) and international conventions.
# It is also subject to database protection according to the Swedish
# Copyright Act.
# Any use of this material to target advertising or
# similar activities is forbidden and will be prosecuted.
# If any of the information below is transferred to a third
# party, it must be done in its entirety. This server must
# not be used as a backend for a search engine.
# Result of search for registered domain names under
# the .se top level domain.
# This whois printout is printed with UTF-8 encoding.
#
state: active
domain: medivir.se
holder: ASCIO4208-153359
admin-c: -
tech-c: -
billing-c: -
created: 1995-08-24
modified: 2016-12-26
expires: 2017-12-31
transferred: 2009-03-07
nserver: ns1.ascio.net
nserver: ns3.ascio.net
nserver: ns2.ascio.net
dnssec: unsigned delegation
status: ok
registrar: Ascio

  REFERRER http://www.nic-se.se

  REGISTRAR NIC-SE

SERVERS

  SERVER se.whois-servers.net

  ARGS medivir.se

  PORT 43

  TYPE domain

DISCLAIMER
Copyright (c) 1997- IIS (The Internet Foundation In Sweden).
All rights reserved.
The information obtained through searches, or otherwise, is protected
by the Swedish Copyright Act (1960:729) and international conventions.
It is also subject to database protection according to the Swedish
Copyright Act.
Any use of this material to target advertising or
similar activities is forbidden and will be prosecuted.
If any of the information below is transferred to a third
party, it must be done in its entirety. This server must
not be used as a backend for a search engine.
Result of search for registered domain names under
the .se top level domain.
This whois printout is printed with UTF-8 encoding.


DOMAIN

STATUS
active
ok

  NAME medivir.se

  CREATED 1995-08-24

  EXPIRES 2017-12-31

NSERVER

  NS1.ASCIO.NET 185.83.100.41

  NS3.ASCIO.NET 185.83.100.43

  NS2.ASCIO.NET 185.83.102.42

OWNER

  HANDLE ASCIO4208-153359

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .